Lorazepam
- Product NDC
- 68071-3096
- 11-digit product format
- 680713096
- Labeler code
- 68071
- Product ID
- 68071-3096_2c292dde-713d-777b-e063-6394a90abf53
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lorazepam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA078203
- Marketing category
- ANDA
- Marketing start
- 2007-10-01
- Substance
- LORAZEPAM
- Active strength
- .5 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lorazepam
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LORAZEPAM | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O26FZP769L |
| Rxcui | 197900 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 68071-3096-3 | 2022-02-07 | C162847 | 48780-1 | 9d75b9d0-ad9b-f424-e053-dadaa90a57ce | Lorazepam Tablets, USP CIV Rx only |
| 68071-3096-4 | 2022-02-07 | C162847 | 48780-1 | 9d75b9d0-ad9b-f424-e053-dadaa90a57ce | Lorazepam Tablets, USP CIV Rx only |
| 68071-3096-3 | 2022-01-28 | C162847 | 48780-1 | 9d75b9d0-ad9b-f424-e053-dadaa90a57ce | Lorazepam Tablets, USP CIV Rx only |
| 68071-3096-4 | 2022-01-28 | C162847 | 48780-1 | 9d75b9d0-ad9b-f424-e053-dadaa90a57ce | Lorazepam Tablets, USP CIV Rx only |
| 68071-3096-3 | 2020-04-23 | C162847 | 48780-1 | 9d75b9d0-ad9b-f424-e053-dadaa90a57ce | Lorazepam Tablets, USP CIV Rx only |
| 68071-3096-4 | 2020-04-23 | C162847 | 48780-1 | 9d75b9d0-ad9b-f424-e053-dadaa90a57ce | Lorazepam Tablets, USP CIV Rx only |
| 68071-3096-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ad9b-f424-e053-dadaa90a57ce | Lorazepam Tablets, USP CIV Rx only |
| 68071-3096-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-ad9b-f424-e053-dadaa90a57ce | Lorazepam Tablets, USP CIV Rx only |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-3096-3 | Lorazepam | 30 in 1 BOTTLE | TABLET | 30 | | 6 |
| 68071-3096-4 | Lorazepam | 45 in 1 BOTTLE | TABLET | 45 | | 6 |
| 68071-3096-6 | Lorazepam | 60 in 1 BOTTLE | TABLET | 60 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-3096 | LORAZEPAM TABLET [NUCARE PHARMACEUTICALS, INC.] | 6 | Current NDC, Legacy NDC, 3 package rows | 20250121_4a66b854-4dd6-3746-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-3096-3 | 68071309603 | 30 TABLET in 1 BOTTLE (68071-3096-3) | 30 tablet | 2017-03-10 | 0000-00-00 | No | No | Current |
| 68071-3096-4 | 68071309604 | 45 TABLET in 1 BOTTLE (68071-3096-4) | 45 tablet | 2017-03-10 | 0000-00-00 | No | No | Current |
| 68071-3096-6 | 68071309606 | 60 TABLET in 1 BOTTLE (68071-3096-6) | 60 tablet | 2017-03-10 | | No | No | Current |